Literature DB >> 35410397

Thalamocortical functional connectivity in infants with prenatal opioid exposure correlates with severity of neonatal opioid withdrawal syndrome.

Rupa Radhakrishnan1, Ramana V Vishnubhotla2, Zoe Guckien3, Yi Zhao4, Gregory M Sokol5, David M Haas6, Senthilkumar Sadhasivam7.   

Abstract

PURPOSE: Prenatal opioid exposure (POE) is a growing public health concern due to its associated adverse outcomes including neonatal opioid withdrawal syndrome (NOWS). The aim of this study was to assess alterations in thalamic functional connectivity in neonates with POE using resting-state functional magnetic resonance imaging (rs-fMRI) and identify whether these altered connectivity measures were associated with NOWS severity.
METHODS: In this prospective, IRB-approved study, we performed rs-fMRI in 19 infants with POE and 20 healthy control infants without POE. Following standard pre-processing, we performed seed-based functional connectivity analysis with the right and left thalamus as the regions of interest. We performed post hoc analysis in the prenatal opioid exposure group to identify associations of altered thalamocortical connectivity with severity of NOWS. P value of < .05 was considered statistically significant.
RESULTS: There were several regions of significantly altered thalamic to cortical functional connectivity in infants with POE compared to the healthy infants. Distinct regions of thalamocortical functional connectivity correlated with maximum modified Finnegan score. Association between thalamocortical connectivity and severity of NOWS was nominally modified by maternal psychological conditions and polysubstance use.
CONCLUSION: Our findings reveal prenatal opioid exposure-related alterations in thalamic functional connectivity in the infant brain that are correlated with severity of NOWS. Future studies may benefit from evaluation of thalamocortical resting state functional connectivity in infants with POE to help  stratify risk of long term neurodevelopmental outcomes.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Brain development; Magnetic resonance imaging; NAS; NOWS; Prenatal opioid exposure; Rs-fMRI

Mesh:

Substances:

Year:  2022        PMID: 35410397     DOI: 10.1007/s00234-022-02939-4

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.995


  52 in total

Review 1.  Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome.

Authors:  Denise J Maguire; Susan Taylor; Kathleen Armstrong; Emily Shaffer-Hudkins; Aaron M Germain; Sandra S Brooks; Genieveve J Cline; Leah Clark
Journal:  Neonatal Netw       Date:  2016

Review 2.  Neonatal Abstinence Syndrome.

Authors:  Karen McQueen; Jodie Murphy-Oikonen
Journal:  N Engl J Med       Date:  2016-12-22       Impact factor: 91.245

Review 3.  Neonatal and longer term management following substance misuse in pregnancy.

Authors:  Helen Mactier
Journal:  Early Hum Dev       Date:  2013-10-07       Impact factor: 2.079

4.  White Matter Injury and Structural Anomalies in Infants with Prenatal Opioid Exposure.

Authors:  S L Merhar; N A Parikh; A Braimah; B B Poindexter; J Tkach; B Kline-Fath
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-17       Impact factor: 3.825

5.  Neonatal Abstinence Syndrome.

Authors:  Leah Khan
Journal:  Pediatr Ann       Date:  2020-01-01       Impact factor: 1.132

6.  Do maternal opioids reduce neonatal regional brain volumes? A pilot study.

Authors:  Q Yuan; M Rubic; J Seah; C Rae; I M R Wright; K Kaltenbach; J M Feller; M E Abdel-Latif; C Chu; J L Oei
Journal:  J Perinatol       Date:  2014-06-19       Impact factor: 2.521

7.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

8.  Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population.

Authors:  Romuladus E Azuine; Yuelong Ji; Hsing-Yuan Chang; Yoona Kim; Hongkai Ji; Jessica DiBari; Xiumei Hong; Guoying Wang; Gopal K Singh; Colleen Pearson; Barry Zuckerman; Pamela J Surkan; Xiaobin Wang
Journal:  JAMA Netw Open       Date:  2019-06-05

9.  Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure: A Systematic Review and Meta-analysis.

Authors:  Su Lynn Yeoh; John Eastwood; Ian M Wright; Rachael Morton; Edward Melhuish; Meredith Ward; Ju Lee Oei
Journal:  JAMA Netw Open       Date:  2019-07-03

10.  Prenatal opioid exposure is associated with smaller brain volumes in multiple regions.

Authors:  Stephanie L Merhar; Julia E Kline; Adebayo Braimah; Beth M Kline-Fath; Jean A Tkach; Mekibib Altaye; Lili He; Nehal A Parikh
Journal:  Pediatr Res       Date:  2020-11-11       Impact factor: 3.756

View more
  1 in total

1.  Brain structural connectome in neonates with prenatal opioid exposure.

Authors:  Ramana V Vishnubhotla; Yi Zhao; Qiuting Wen; Jonathan Dietrich; Gregory M Sokol; Senthilkumar Sadhasivam; Rupa Radhakrishnan
Journal:  Front Neurosci       Date:  2022-09-16       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.